John C Reed - Net Worth and Insider Trading

John C Reed Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John C Reed owns 3 companies in total, including Ionis Pharmaceuticals Inc (IONS) , Clovis Oncology Inc (CLVSQ) , and Johnson & Johnson (JNJ) .

Click here to see the complete history of John C Reed’s form 4 insider trades.

Insider Ownership Summary of John C Reed

Ticker	Company	Transaction Date	Type of Owner
IONS	Ionis Pharmaceuticals Inc	2003-07-01	director
CLVSQ	Clovis Oncology Inc	2012-06-14	director
JNJ	Johnson & Johnson	2023-04-03	EVP & Pharmaceuticals R&D

John C Reed Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John C Reed Ownership Network

Ownership Network List of John C Reed

No Data

Ownership Network Relation of John C Reed

John C Reed Owned Company Details

What does Ionis Pharmaceuticals Inc do?

Who are the key executives at Ionis Pharmaceuticals Inc?

John C Reed is the director of Ionis Pharmaceuticals Inc. Other key executives at Ionis Pharmaceuticals Inc include EVP & Corp and Development Ops Brian Birchler , Chief Business Officer Joseph Baroldi , and director & Senior Vice President Brett P Monia .

Ionis Pharmaceuticals Inc (IONS) Insider Trades Summary

Over the past 18 months, John C Reed made no insider transaction in Ionis Pharmaceuticals Inc (IONS). Other recent insider transactions involving Ionis Pharmaceuticals Inc (IONS) include a net sale of 246,346 shares made by Brett P Monia , a net sale of 55,113 shares made by Patrick R. O'neil , and a net sale of 44,078 shares made by Richard S Geary .

In summary, during the past 3 months, insiders sold 75,734 shares of Ionis Pharmaceuticals Inc (IONS) in total and bought 0 shares, with a net sale of 75,734 shares. During the past 18 months, 752,955 shares of Ionis Pharmaceuticals Inc (IONS) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 747,955 shares.

Ionis Pharmaceuticals Inc (IONS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ionis Pharmaceuticals Inc Insider Transactions

No Available Data

What does Clovis Oncology Inc do?

Who are the key executives at Clovis Oncology Inc?

John C Reed is the director of Clovis Oncology Inc. Other key executives at Clovis Oncology Inc include See Remarks Thomas C. Harding , See Remarks Gillian C Ivers-read , and See remarks Lindsey Rolfe .

Clovis Oncology Inc (CLVSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Clovis Oncology Inc (CLVSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clovis Oncology Inc (CLVSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Clovis Oncology Inc (CLVSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Clovis Oncology Inc Insider Transactions

No Available Data

What does Johnson & Johnson do?

Who are the key executives at Johnson & Johnson?

John C Reed is the EVP & Pharmaceuticals R&D of Johnson & Johnson. Other key executives at Johnson & Johnson include Controller & CAO Robert J Decker , EVP & WW Chair & MedTech Timothy Schmid , and Exec VP & CFO Joseph J Wolk .

Johnson & Johnson (JNJ) Insider Trades Summary

Over the past 18 months, John C Reed made no insider transaction in Johnson & Johnson (JNJ). Other recent insider transactions involving Johnson & Johnson (JNJ) include a net sale of 12,634 shares made by Robert J Decker , a net sale of 59,397 shares made by Jennifer L Taubert , and a net sale of 13,015 shares made by Joseph J Wolk .

In summary, during the past 3 months, insiders sold 20,417 shares of Johnson & Johnson (JNJ) in total and bought 0 shares, with a net sale of 20,417 shares. During the past 18 months, 94,340 shares of Johnson & Johnson (JNJ) were sold and 1,000 shares were bought by its insiders, resulting in a net sale of 93,340 shares.

Johnson & Johnson (JNJ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Johnson & Johnson Insider Transactions

No Available Data

John C Reed Mailing Address

Above is the net worth, insider trading, and ownership report for John C Reed. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, John C Reed's mailing address is: New Brunswick Nj 08933.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.